高级检索
当前位置: 首页 > 详情页

Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer

文献详情

资源类型:
机构: [1]Univ South China, Affiliated Hosp 2, Dept Pathol, Hengyang, Hunan, Peoples R China [2]Univ South China, Canc Res Inst, Key Lab Canc Cellular & Mol Pathol Hunan Prov Uni, Hengyang, Hunan, Peoples R China [3]Cent S Univ, Xiangya Sch Med, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, Changsha, Hunan, Peoples R China [4]Cent S Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Hunan, Peoples R China [5]Univ South China, Affiliated Hosp 1, Dept Gastroenterol, Hengyang, Hunan, Peoples R China
出处:
ISSN:

摘要:
This study aimed to explore whether the downregulation of LIM kinase 1 (LIMK1)-actin depolymerization factor (ADF, also known as destrin)/cofilin by diallyl disulfide (DADS) inhibited the migration and invasion of colon cancer. Previous studies have shown that silencing LIMK1 could significantly enhance the inhibitory effect of DADS on colon cancer cell migration and invasion, suggesting that LIMK1 was a target molecule of DADS, which needed further confirmation. This study reported that LIMK1 and destrin were highly expressed in colon cancer and associated with poor prognosis of patients with colon cancer. Also, the expression of LIMK1 was positively correlated with the expression of destrin. The overexpression of LIMK1 significantly promoted colon cancer cell migration and invasion. DADS obviously inhibited migration and invasion by suppressing the phosphorylation of ADF/cofilin via downregulation of LIMK1 in colon cancer cells. Furthermore, DADS-induced suppression of cell proliferation was enhanced and antagonized by the knockdown and overexpression of LIMK1 in vitro and in vivo, respectively. Similar results were observed for DADS-induced changes in the expression of vimentin, CD34, Ki-67, and E-cadherin in xenografted tumors. These results indicated that LIMK1 was a potential target molecule for the inhibitory effect of DADS on colon cancer cell migration and invasion.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
最新[2023]版:
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
第一作者:
第一作者机构: [1]Univ South China, Affiliated Hosp 2, Dept Pathol, Hengyang, Hunan, Peoples R China [2]Univ South China, Canc Res Inst, Key Lab Canc Cellular & Mol Pathol Hunan Prov Uni, Hengyang, Hunan, Peoples R China
通讯作者:
通讯机构: [2]Univ South China, Canc Res Inst, Key Lab Canc Cellular & Mol Pathol Hunan Prov Uni, Hengyang, Hunan, Peoples R China [3]Cent S Univ, Xiangya Sch Med, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, Changsha, Hunan, Peoples R China [4]Cent S Univ, Xiangya Sch Med, Affiliated Canc Hosp, Changsha, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号